XNYS
TRLV
Market cap1.96bUSD
Nov 06, Last price
11.56USD
1D
6.06%
1Q
32.11%
IPO
0.52%
Name
Trulieve Cannabis Corp
Chart & performance
P/E
—
P/S
1.67
EPS
—
Vol. 1Y
—
Shs. 5Y
10.08%
Rev. 5Y
17.76%
Div Yld LY
—
Div Yld TTM
—
Revenues
1.18b
-0.45%
Net income
-116m
L-24.97%
CFO
273m
+0.49%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Trulieve Cannabis Corp. engages in the cultivation, processing, manufacturing, and retail distribution of medical and adult-use cannabis products. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers & Jason Pernell on September 17, 1940 and is headquartered in Tallahassee, FL.
Related entities
Subsidiaries
Trulieve Capps Highway LLC
Key people
Kim Rivers
Chairman of the Board, Chief Executive Officer · since 2021
Jason Pernell
President · since 2025
Jan Reese
Chief Financial Officer · since 2025
Marie Zhang
Chief Operating Officer · since 2024
Joy Malivuk
Chief Accounting Officer · since 2023
Gina Collins
Chief Marketing Officer · since 2022
Kyle Landrum
Chief Production Officer · since 2019
Timothy Morey
Chief Sales Officer · since 2019
Eric Powers
Chief Legal Officer and Corporate Secretary · since 2021
Peter Healy
Lead Independent Director · since 2021
Director · since 2025
Thad Beshears
Independent Director · since 2015
Richard May
Independent Director · since 2015
Independent Director · since 2020
Independent Director · since 2021
Susan Thronson
Independent Director · since 2020
Legal address
Suite 2800, Park Place
666 Burrard Street
Vancouver, BC V6C 2Z7
CA
666 Burrard Street
Vancouver, BC V6C 2Z7
CA
Headquarters
3494 Martin Hurst Road
Tallahassee, FL 32312
US
Tallahassee, FL 32312
US
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||